PATENT CLAIM ANALYSIS

Application Number: 16101861
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "158100"]

Abstract:
Antibodies that bind the apple 2 domain of human coagulation Factor XI and inhibit activation of FXI by coagulation factor XIIa are described.

Claim (Index 38):
The method of  claim 34  wherein the therapeutically effective amount of the antibody or antigen binding fragment comprises about 0.3 to about 3.0 mg of the antibody or antigen binding fragment/kg of the subject.

Metadata:
- Claim Count in Document: 122.0
- Percentile: 96.0
- Lexical Diversity: 1.09091
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15409607', '15619620', '16335133', '15906773', '15934526']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7867459582395326
- 35 USC 102 Novelty (BERT): 0.6947766864906446
- Combined Prediction Score: 0.7775490310646439
- Mean Citation Score: 558.16293
- Max Citation Score: 887.4425699999997
- Similarity Product: 678.5504189546887

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test